Very rarely. J&J can affect the heart.

The question asks whether the J&J vaccine could have caused heart problems. Large safety studies found heart inflammation clearly linked to mRNA vaccines and, in some analyses, to the AstraZeneca vaccine. For J&J, good data are limited and no clear heart-inflammation signal has been established. This means the link is not shown, not that it is excluded. The established serious risk is TTS, which is very rare and mainly affects other organs. Heart problems have many causes, so one person's case can't be traced to the vaccine from this evidence alone. If you have symptoms such as chest pain, shortness of breath or palpitations, a doctor can check them. A doctor can also report a suspected vaccine reaction to VAERS or your national system.

• Myocarditis and pericarditis are well documented, mostly in young men, after mRNA vaccines (Pfizer and Moderna). Evidence for the J&J vaccine is sparse and has not shown a clear signal.
• The J&J vaccine's recognised serious risks are thrombosis with thrombocytopenia syndrome (TTS), at about 3 to 4 cases per million doses in the US, and Guillain-Barré syndrome.
• TTS clots most often occur in the brain's veins or in the abdomen, not usually in the heart.
• US authorization of the J&J vaccine ended in June 2023, and far fewer people received it than the mRNA vaccines, so data on rare effects are limited.
• Covid infection itself can cause heart complications.

A vaccine-related cause is possible, but timing alone does not establish it. The recognized heart-inflammation risk concerns symptoms beginning shortly after vaccination, particularly within the first few weeks. What heart problem were you diagnosed with, when did you receive the vaccine, and how soon afterward did symptoms begin? A clinician can review that timeline and your test results. If you currently have chest pain or shortness of breath, seek immediate medical attention; call 911 for severe symptoms or fainting.

• J&J-specific safety evidence identifies increased myocarditis/pericarditis risk, particularly in men aged 18–39 within 28 days of vaccination.
• The vaccine's risk-management report describes these reactions as very rare, while EMA lists their precise frequency as unknown.
• A separate complication, clotting with low platelets, occurred at approximately 4 cases per million J&J doses overall, with the highest rates in women aged 30–49; this is not a rate for heart inflammation.
• COVID-19 infection itself can also cause myocarditis and pericarditis.

1. fda.gov
2. fda.gov
3. fda.gov
4. cdc.gov
5. fda.gov
6. fda.gov
7. fda.gov
8. cdc.gov

Safety surveillance systems monitored cardiovascular outcomes following administration of the Johnson & Johnson (Janssen) viral-vector COVID-19 vaccine. While heart inflammation—specifically myocarditis and pericarditis—was primarily associated with mRNA vaccines, health authorities, including the US Food and Drug Administration, also identified and confirmed a small number of post-vaccination myocarditis cases with the Janssen shot, leading to updated warning sheets in 2023. These events were classified as extremely rare, documented in fewer than 1 in 100,000 recipients, and most cases improved with prompt medical care. Because heart conditions have dozens of potential medical causes and the risk of cardiac damage from active viral infections is substantially higher, people experiencing cardiovascular symptoms should undergo direct clinical evaluation.

• Health regulators including the US FDA updated Janssen safety information to acknowledge an extremely rare risk of myocarditis and pericarditis.
• Post-authorization monitoring identified roughly 4 to 5 adjudicated cases of heart inflammation per million doses given.
• The vaccine was also linked to thrombosis with thrombocytopenia syndrome (TTS), an extremely rare blood-clotting disorder.
• Cardiovascular complications, including myocarditis and heart attacks, occur far more frequently after COVID-19 infection than after receiving the vaccine.
• Anyone experiencing chest pain, rapid heartbeat, or shortness of breath should be assessed by a physician to identify the underlying cause.

The question asks whether the J&J vaccine could have caused heart problems in the person asking. Inflammation of the heart muscle or lining has been reported after COVID-19 vaccination, including with the Janssen/Ad26.COV2.S vaccine, so a rare causal link is accepted rather than ruled out — hence yes, with the frequency on the order of very rare. The J&J-specific evidence base is much thinner than for the mRNA vaccines, which is why the evidence rating is mixed, and an individual case cannot be attributed from a general risk figure; timing after vaccination and a medical work-up are what distinguish vaccine-associated cases from other causes.

• Myocarditis and pericarditis are listed as rare side effects of COVID-19 vaccines; the clearest data are for the mRNA vaccines, with reported cases after the Janssen (J&J) vaccine too.
• Estimated myocarditis rates after mRNA vaccination are highest in males aged under 30, around 1 in 10,000 to 1 in 20,000 after a second dose; rates reported after the J&J shot are lower, on the order of a few per 100,000 doses or less.
• Most vaccine-linked cases occur within days to about two weeks of vaccination and improve with rest and treatment.
• The risk of myocarditis from COVID-19 infection itself is substantially higher than from vaccination.
• The better-documented rare risks of the J&J vaccine are thrombosis with thrombocytopenia syndrome (about 9 per million doses in women aged 18-49) and Guillain-Barré syndrome; VAERS reports such as one pericarditis entry 1,522 days after vaccination are unverified and do not establish cause.

1. You know, maybe the easiest way that I can put it is these vaccines are more reactogenic than something people are very familiar... newsnetwork.mayoclinic.org
2. Debunking COVID-19 myths - Misinformation is often a mix of true and false ideas amerikanhastanesi.org
3. Headline: [VIDEO] Keep calm & jab on: These numbers will boost your faith in COVID- 19 vaccines bhekisisa.org
4. Most cases of TTS reported to the Vaccine Adverse Event Reporting System (VAERS) following receipt of the J&J/Janssen COVID- 19 ... library.bannerhealth.com
5. This is VAERS ID 2892987 medalerts.org
6. COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance - After issuance of an EUA of the Johnson & Johnson (Janssen) COVID-19 vaccine, which was granted February 27, 2021, its use was p... pmc.ncbi.nlm.nih.gov

The question asks whether the Johnson & Johnson Covid vaccine could have caused heart problems, specifically heart inflammation (myocarditis or pericarditis). The evidence shows that, unlike the mRNA Covid vaccines (Pfizer and Moderna), the Johnson & Johnson vaccine has not been linked to heart inflammation. The FDA and CDC have not observed a pattern of myocarditis or pericarditis after the J&J vaccine, and major health organizations (Mayo Clinic, Nebraska Medicine, VCU Health, NBC News) confirm this. The J&J vaccine is associated with a very rare risk of blood clots (TTS), but not heart muscle or lining inflammation. The risk of heart problems from Covid-19 infection itself is much higher than any vaccine-related risk.

• The FDA and CDC have not found a pattern of heart inflammation (myocarditis/pericarditis) after the Johnson & Johnson Covid vaccine.
• Heart inflammation is a rare side effect of mRNA Covid vaccines (Pfizer, Moderna), mostly in young men, but not linked to J&J.
• The Johnson & Johnson vaccine is associated with a very rare risk of blood clots (TTS), estimated at 5.8 cases per million doses in women aged 18–49.
• The risk of heart problems from Covid-19 infection is much higher than any vaccine-related risk.
• Health authorities continue to recommend Covid vaccination for people with heart disease, as the benefits outweigh the risks.

1. Debunking COVID-19 myths - Mayo Clinic mayoclinic.org
2. You asked, we answered: Do the COVID-19 vaccines cause blood clots or heart problems? | Nebraska Medicine Omaha, NE nebraskamed.com
3. FDA flags J&J's COVID-19 vaccine for myocarditis, pericarditis risk - Becker's Hospital Review | Healthcare News & Analysis beckershospitalreview.com
4. Cardiovascular complications of COVID-19 vaccines - PMC pmc.ncbi.nlm.nih.gov
5. FDA Adds New Warning to Johnson & Johnson’s COVID-19 Vaccine Fact Sheet individual.carefirst.com
6. COVID-19 vaccination and heart failure: Is there a link? medicalnewstoday.com
7. Cardiac complications of COVID-19 vaccination: now we know ... pmc.ncbi.nlm.nih.gov
8. COVID 19 vaccine and heart patients Is it safe | VCU Health vcuhealth.org